Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Vertex Pharmaceuticals is backed by CF dominance and JOURNAVX optionality, with key catalysts ahead for growth and upside.

Vertex Pharmaceuticals ( VRTX +0.01%) has been a top pharma stock in recent years. It has been generating strong revenue growth while also building out its portfolio of drugs, expanding its growth ...

Vertex Pharmaceuticals (NASDAQ:VRTX) has had a rough month with its share price down 15%. However, stock prices ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.31, along with a high estimate of $553.00 and a low estimate of $405.00. Experiencing ...

Three stocks that look incredibly cheap right now which you may want to consider buying are Vertex Pharmaceuticals ( VRTX ...

Learn more about whether Sapiens International Corporation N.V. or Vertex, Inc. is a better investment based on AAII's A+ ...

On August 7, a substantial insider purchase was made by BRUCE SACHS, Board Member at Vertex Pharmaceuticals VRTX, as per the latest SEC filing. What Happened: SACHS's recent move, as outlined in a ...

Vertex Pharmaceuticals stock sold off on two pipeline disappointments. The biotech company continues to grow with promising new drugs on the horizon. Vertex's price looks quite attractive, relative to ...

Vertex, Inc. (NASDAQ:VERX) is one of the Tech Stocks to Buy with the Highest Upside Potential. Wall Street has a mixed ...